COMMUNIQUÉS West-GlobeNewswire

Idorsia announces financial results for 2018 - outstanding progress made - four late stage assets advanced into Phase 3

07/02/2019 - 07:01

Allschwil, Switzerland - February 7, 2019 Idorsia Ltd (SIX: IDIA) today announced its financial results for the full year 2018. Key Updates Advancing pipeline - four Phase 3 programs initiated Operational independence [...]

Precision Optics Corporation Schedules Second Quarter Conference Call

07/02/2019 - 04:51

GARDNER, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced that it intends to release its financial results for the fiscal year 2019 second quarter [...]

RavenQuest Issues Statement in Response to Health Canada Sales License Suspension at Bonify

07/02/2019 - 02:45

VANCOUVER, British Columbia, Feb. 06, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) CEO, George Robinson, also acting President & CEO at [...]

Hemispherx Biopharma Announces Key Dates and Timeline for Stockholder Participation in Rights Offering

06/02/2019 - 23:34

OCALA, Fla., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical [...]

New England Journal of Medicine Publishes Results from Pivotal Phase 3 Studies of Paratek’s NUZYRA™ (Omadacycline) For Pneumonia and Skin Infections

06/02/2019 - 23:05

Once-daily IV-to-oral NUZYRA safe and effective in adults with pneumonia and skin infections, demonstrating clinical activity against relevant pneumonia- and skin-associated drug resistant bacteria BOSTON, Feb. 06, 2019 [...]

LeMaitre Vascular Will Announce Fourth Quarter 2018 Earnings Results on February 19, 2019

06/02/2019 - 22:30

BURLINGTON, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2018 financial results on Tuesday, February 19, 2019, after the market [...]

RavenQuest and Bonify Announce One-Year Extension of Services Agreement

06/02/2019 - 22:27

VANCOUVER, British Columbia, Feb. 06, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) announces that RavenQuest will continue to provide [...]

The Ensign Group Reports Fourth Quarter and Fiscal Year 2018 Results

06/02/2019 - 22:08

Conference Call and Webcast scheduled for tomorrow, February 7, 2019 at 10:00 am PT MISSION VIEJO, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group [...]

HealthEquity Reports Year-End Sales Metrics

06/02/2019 - 22:07

Custodial Assets of $8.1 billion, up 19% year-over-year, HSA Members up 17% DRAPER, Utah, Feb. 06, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), one of the nation's largest [...]

Misonix Fiscal 2019 Second Quarter Revenue Rises 22% to a Record $10.2 Million

06/02/2019 - 22:05

FARMINGDALE, N.Y., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]

Conformis Reports Fourth Quarter and Year Ended 2018 Financial Results

06/02/2019 - 22:05

BILLERICA, Mass., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]

Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director

06/02/2019 - 22:01

Press Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director Notes the resignation of Christian Mulliez as [...]

Le Conseil d'administration de Sanofi prend acte de la démission de Christian Mulliez et coopte Christophe Babule en tant que nouvel administrateur

06/02/2019 - 22:01

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NASDAQ : SNY) Le Conseil d'administration de Sanofi prend acte de la démission de Christian Mulliez et coopte Christophe Babule en tant que nouvel administrateur [...]

OraSure Announces 2018 Full Year and Fourth Quarter Financial Results

06/02/2019 - 22:00

BETHLEHEM, Pa., Feb. 06, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the full [...]

Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date

06/02/2019 - 20:40

BATON ROUGE, La., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the fourth quarter and year ended December 31, 2018, after the market closes on February [...]

Sanofi: FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

06/02/2019 - 17:45

FDA approves Cablivi ® (caplacizumab-yhdp), the first Nanobody ® -based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP) First medicine approved in the U.S. specifically for the treatment of [...]

Sanofi : La FDA approuve Cablivi® (caplacizumab-yhdp), le premier médicament à base de Nanobody® pour le traitement du purpura thrombotique thrombocytopénique (PTT) acquis de l'adulte

06/02/2019 - 17:45

La FDA approuve Cablivi ® (caplacizumab-yhdp), le premier médicament à base de Nanobody ® pour le traitement du purpura thrombotique thrombocytopénique (PTT) acquis de l'adulte Premier médicament spécifiquement approuvé [...]

Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2019

06/02/2019 - 17:45

LYON, France, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: [...]

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 Janvier 2019

06/02/2019 - 17:45

LYON, France, 06 févr. 2019 (GLOBE NEWSWIRE) -- Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : [...]